Showing 781 - 800 results of 74,138 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((ns decrease) OR (a decrease)) ))', query time: 1.23s Refine Results
  1. 781
  2. 782
  3. 783

    Inhibition of GLS1 decreases the proportion of CCR6 and CXCR3 expressing CD4<sup>+</sup> T cells. by Zeynep Sener (3146064)

    Published 2016
    “…BPTES and 968 significantly decrease the proportion of CCR6 expressing cells under normoxia both at day 3 and 5, whereas 968 but not BPTES decrease the proportion of CCR6 expressing cells under hypoxia both at day 3 and 5. …”
  4. 784
  5. 785

    Fig 7 - by C. Vijay Reena Durai (14498259)

    Published 2023
    Subjects:
  6. 786
  7. 787
  8. 788
  9. 789

    Fig 1 - by C. Vijay Reena Durai (14498259)

    Published 2023
    Subjects:
  10. 790
  11. 791
  12. 792
  13. 793
  14. 794

    U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

    Published 2014
    “…The inoculation of U87MG gal-3 shRNA cells in the flank of nuce mice (n = 5) demonstrated a decrease in tumor size and growth compared to the U87MG scramble shRNA (n = 6). …”
  15. 795

    Female EIIIA-cFN null mice have decreased accumulation of intracellular lipids at day 2 after PHx. by Bridget Sackey-Aboagye (3221319)

    Published 2016
    “…(E, F)</b> Quantification of percent Oil Red O covered area, mean +/- SD, * p<0.05. Scale bar, 50 μm. (EIIIA<sup>+/+</sup> = 10; 5 female, 5 male; EIIIA<sup>-/-</sup> = 10; 4 female, 6 male).…”
  16. 796
  17. 797
  18. 798

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”
  19. 799
  20. 800

    The surface area of breast tumors in PyMT transgenic mice was decreased after three weeks of voluntary wheel running. by Jorming Goh (490491)

    Published 2013
    “…Runners have a significant decrease in tumor size in mammary gland 1 after 5 weeks of running (p = 0.03). …”